View in EDS

Geneva Homologous Recombination Deficiency Test Is Predictive of Survival Benefit From Olaparib and Bevacizumab Maintenance in Ovarian Cancer.

Saved in:
Bibliographic Details
Title: Geneva Homologous Recombination Deficiency Test Is Predictive of Survival Benefit From Olaparib and Bevacizumab Maintenance in Ovarian Cancer.
Authors: Christinat Y; Department of Clinical Pathology, Hôpitaux Universitaires de Genève, Geneva, Switzerland., Labidi-Galy I; Department of Oncology, Hôpitaux Universitaires de Genève, Geneva, Switzerland.; Faculty of Medicine, Université de Genève, Geneva, Switzerland.; SAKK, Bern, Switzerland., Ho L; Department of Clinical Pathology, Hôpitaux Universitaires de Genève, Geneva, Switzerland., Clément S; Faculty of Medicine, Université de Genève, Geneva, Switzerland., Genestie C; Gustave Roussy, Paris, France., Sehouli J; Charité-Universitätsmedizin Berlin (CVK) and AGO, Berlin, Germany., Cinieri S; U.O.C. Oncologia Medica-Ospedale Senatore Antonio Perrino, Brindisi, Italy.; MITO, Brindisi, Italy., Gonzalez-Martin A; Medical Oncology Department, Clinica Universidad de Navarra, Madrid, Spain.; GEICO, Madrid, Spain., Kolovetsiou-Kreiner V; Department of Obstetrics and Gynecology, Division of Gynecology, Medical University of Graz, Graz, Austria.; AGO Austria, Graz, Austria., Fujiwara K; Saitama Medical University International Medical Center and GOTIC, Saitama, Japan., Von Gorp T; Belgium and Luxembourg Gynaecological Oncology Group, University Hospitals Leuven and Leuven Cancer Institute, Leuven, Belgium.; BGOG, Leuven, Belgium., Tognon G; Spedali Civili di Brescia and MaNGO, Brescia, Italy., Hietanen S; Department of Obstetrics and Gynecology, Turku University Hospital, Turku, Finland.; NSGO-CTU, Copenhagen, Denmark., Heinzelmann-Schwarz V; SAKK, Bern, Switzerland.; Women University Hospital, University Hospital Basel, Basel, Switzerland., Ray-Coquard I; Centre Leon Bérard and University Claude Bernard Lyon I and GINECO, Lyon, France.; ARCAGY-GINECO, Paris, France., Pujade-Lauraine E; ARCAGY-GINECO, Paris, France., McKee TA; Department of Clinical Pathology, Hôpitaux Universitaires de Genève, Geneva, Switzerland.; Faculty of Medicine, Université de Genève, Geneva, Switzerland.
Source: JCO precision oncology [JCO Precis Oncol] 2025 Jul; Vol. 9, pp. e2400825. Date of Electronic Publication: 2025 Jul 02.
Publication Type: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial
Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40601896
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Geneva Homologous Recombination Deficiency Test Is Predictive of Survival Benefit From Olaparib and Bevacizumab Maintenance in Ovarian Cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Christinat+Y%22">Christinat Y</searchLink>; Department of Clinical Pathology, Hôpitaux Universitaires de Genève, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Labidi-Galy+I%22">Labidi-Galy I</searchLink>; Department of Oncology, Hôpitaux Universitaires de Genève, Geneva, Switzerland.; Faculty of Medicine, Université de Genève, Geneva, Switzerland.; SAKK, Bern, Switzerland.<br /><searchLink fieldCode="AU" term="%22Ho+L%22">Ho L</searchLink>; Department of Clinical Pathology, Hôpitaux Universitaires de Genève, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Clément+S%22">Clément S</searchLink>; Faculty of Medicine, Université de Genève, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Genestie+C%22">Genestie C</searchLink>; Gustave Roussy, Paris, France.<br /><searchLink fieldCode="AU" term="%22Sehouli+J%22">Sehouli J</searchLink>; Charité-Universitätsmedizin Berlin (CVK) and AGO, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Cinieri+S%22">Cinieri S</searchLink>; U.O.C. Oncologia Medica-Ospedale Senatore Antonio Perrino, Brindisi, Italy.; MITO, Brindisi, Italy.<br /><searchLink fieldCode="AU" term="%22Gonzalez-Martin+A%22">Gonzalez-Martin A</searchLink>; Medical Oncology Department, Clinica Universidad de Navarra, Madrid, Spain.; GEICO, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Kolovetsiou-Kreiner+V%22">Kolovetsiou-Kreiner V</searchLink>; Department of Obstetrics and Gynecology, Division of Gynecology, Medical University of Graz, Graz, Austria.; AGO Austria, Graz, Austria.<br /><searchLink fieldCode="AU" term="%22Fujiwara+K%22">Fujiwara K</searchLink>; Saitama Medical University International Medical Center and GOTIC, Saitama, Japan.<br /><searchLink fieldCode="AU" term="%22Von+Gorp+T%22">Von Gorp T</searchLink>; Belgium and Luxembourg Gynaecological Oncology Group, University Hospitals Leuven and Leuven Cancer Institute, Leuven, Belgium.; BGOG, Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Tognon+G%22">Tognon G</searchLink>; Spedali Civili di Brescia and MaNGO, Brescia, Italy.<br /><searchLink fieldCode="AU" term="%22Hietanen+S%22">Hietanen S</searchLink>; Department of Obstetrics and Gynecology, Turku University Hospital, Turku, Finland.; NSGO-CTU, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Heinzelmann-Schwarz+V%22">Heinzelmann-Schwarz V</searchLink>; SAKK, Bern, Switzerland.; Women University Hospital, University Hospital Basel, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Ray-Coquard+I%22">Ray-Coquard I</searchLink>; Centre Leon Bérard and University Claude Bernard Lyon I and GINECO, Lyon, France.; ARCAGY-GINECO, Paris, France.<br /><searchLink fieldCode="AU" term="%22Pujade-Lauraine+E%22">Pujade-Lauraine E</searchLink>; ARCAGY-GINECO, Paris, France.<br /><searchLink fieldCode="AU" term="%22McKee+TA%22">McKee TA</searchLink>; Department of Clinical Pathology, Hôpitaux Universitaires de Genève, Geneva, Switzerland.; Faculty of Medicine, Université de Genève, Geneva, Switzerland.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101705370%22">JCO precision oncology</searchLink> [JCO Precis Oncol] 2025 Jul; Vol. 9, pp. e2400825. <i>Date of Electronic Publication: </i>2025 Jul 02.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Clinical+Oncology%22">American Society of Clinical Oncology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101705370 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2473-4284 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224734284%22">24734284 </searchLink><i>NLM ISO Abbreviation: </i>JCO Precis Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40601896
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1200/PO-24-00825
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e2400825
    Titles:
      – TitleFull: Geneva Homologous Recombination Deficiency Test Is Predictive of Survival Benefit From Olaparib and Bevacizumab Maintenance in Ovarian Cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Christinat Y
      – PersonEntity:
          Name:
            NameFull: Labidi-Galy I
      – PersonEntity:
          Name:
            NameFull: Ho L
      – PersonEntity:
          Name:
            NameFull: Clément S
      – PersonEntity:
          Name:
            NameFull: Genestie C
      – PersonEntity:
          Name:
            NameFull: Sehouli J
      – PersonEntity:
          Name:
            NameFull: Cinieri S
      – PersonEntity:
          Name:
            NameFull: Gonzalez-Martin A
      – PersonEntity:
          Name:
            NameFull: Kolovetsiou-Kreiner V
      – PersonEntity:
          Name:
            NameFull: Fujiwara K
      – PersonEntity:
          Name:
            NameFull: Von Gorp T
      – PersonEntity:
          Name:
            NameFull: Tognon G
      – PersonEntity:
          Name:
            NameFull: Hietanen S
      – PersonEntity:
          Name:
            NameFull: Heinzelmann-Schwarz V
      – PersonEntity:
          Name:
            NameFull: Ray-Coquard I
      – PersonEntity:
          Name:
            NameFull: Pujade-Lauraine E
      – PersonEntity:
          Name:
            NameFull: McKee TA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2025 Jul
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2473-4284
          Numbering:
            – Type: volume
              Value: 9
          Titles:
            – TitleFull: JCO precision oncology
              Type: main
ResultId 1